Enterococcus faecalis in a urine culture means this bacterium was detected in your urinary tract, but it doesn’t automatically mean you have an infection that needs treatment. E. faecalis is a normal inhabitant of the human gut that can migrate to the urinary tract and either cause a genuine urinary tract infection (UTI) or simply be present without causing harm. The distinction between these two scenarios is the single most important thing your doctor needs to figure out.
Infection vs. Harmless Colonization
When E. faecalis shows up on a urine culture, it falls into one of two categories: a symptomatic UTI or what’s called asymptomatic bacteriuria, meaning bacteria are present but aren’t causing problems. In one study of 339 patients with enterococcal bacteria in their urine, 183 (about 54%) had asymptomatic bacteriuria, not an active infection. This matters because treating bacteria that aren’t causing symptoms contributes to antibiotic resistance without helping you. In that same study, roughly a third of patients with asymptomatic bacteriuria were inappropriately given antibiotics.
Medical guidelines are clear: antibiotics should not be prescribed without evidence that you’re actually symptomatic. If you have no burning, urgency, fever, or pelvic pain, the bacteria may simply be colonizing your urinary tract temporarily. The major exceptions are pregnant women, organ transplant recipients, and people about to undergo urological procedures, who may benefit from treatment even without symptoms.
How E. Faecalis Differs From Typical UTI Bacteria
Most UTIs are caused by E. coli. Enterococcus faecalis is a less common culprit, and it behaves differently in a few key ways. It’s primarily associated with healthcare settings: people who’ve had catheters, recent hospitalization, urinary retention, or prior courses of antibiotics. Men between 55 and 75 are at higher risk than the general population. That said, E. faecalis does cause a small percentage of community-acquired infections in otherwise healthy people.
One feature that makes E. faecalis particularly stubborn is its ability to form biofilms. These are structured communities of bacteria that attach to the lining of the bladder or to catheters and become far more resistant to antibiotics than free-floating bacteria. Research shows that virtually all E. faecalis urinary isolates are capable of forming biofilms, and most form moderate to strong ones. The bacteria produce tiny hair-like structures called pili that help them grip onto tissue, along with proteins that let them stick to the cells lining your urinary tract and kidneys. This combination of adhesion and biofilm formation is part of why enterococcal UTIs can be harder to clear.
Symptoms to Watch For
When E. faecalis does cause a symptomatic UTI, the symptoms are similar to any other bacterial UTI: burning during urination, frequent or urgent need to urinate, cloudy or foul-smelling urine, and pelvic or lower abdominal discomfort. Fever, flank pain, or chills suggest the infection may have reached the kidneys, which is more serious and typically requires more aggressive treatment.
Your doctor will look at your symptoms alongside the culture results. The presence of white blood cells in your urine (a sign of inflammation) combined with a positive culture is a stronger indicator of true infection than a positive culture alone. Research has found that even bacterial counts below the traditional 100,000 colony-forming units per milliliter threshold can represent genuine infection if white blood cells are also elevated. There’s no single cutoff number that reliably separates infection from colonization with enterococcus, so the clinical picture matters as much as the lab results.
Recurrence Rates
E. faecalis UTIs recur more often than E. coli UTIs. A large German study found that 25.9% of patients with E. faecalis in their urine experienced recurrence, compared to 22.2% for E. coli. Recurrence increases with age: about 12% in adults aged 18 to 29, rising to 28% in those 70 and older. The biofilm-forming ability of the bacteria likely plays a role, as bacteria embedded in biofilms can survive antibiotic courses and re-emerge once treatment ends.
Antibiotic Resistance Concerns
Enterococci are naturally resistant to several common antibiotics, which limits treatment options compared to a straightforward E. coli UTI. The bigger concern is vancomycin-resistant enterococci (VRE), strains that have developed resistance to one of the last-resort antibiotics. VRE is associated with higher mortality, greater healthcare costs, and very few remaining treatment options. Unnecessary antibiotic use in patients who are merely colonized, not infected, has become a significant driver of VRE in hospitals and long-term care facilities.
For standard (non-resistant) E. faecalis UTIs, ampicillin is generally the first-choice antibiotic. For uncomplicated bladder infections, oral options with good activity against enterococci include nitrofurantoin and fosfomycin. If the strain is vancomycin-resistant but still ampicillin-susceptible, ampicillin remains the preferred treatment. Stronger antibiotics are reserved for complicated or bloodstream infections involving resistant strains.
E. Faecalis in Pregnancy
Pregnant women are one group where asymptomatic bacteriuria typically does warrant treatment, because untreated urinary bacteria during pregnancy raise the risk of kidney infection and preterm delivery. In studies of pregnant women, E. faecalis strains were consistently susceptible to ampicillin, amoxicillin, and nitrofurantoin, while showing resistance to several other commonly used antibiotics. Nitrofurantoin is considered a suitable choice in the second and third trimesters, with first-trimester use limited to situations where no better alternative exists.
Connection to Prostatitis in Men
In men, E. faecalis in the urine can sometimes point to bacterial prostatitis rather than a simple bladder infection. Enterococcus species are responsible for an estimated 5 to 10% of prostatitis cases. Treating enterococcal prostatitis is challenging because few antibiotics can both kill the bacteria and penetrate prostate tissue effectively. Standard fluoroquinolone antibiotics achieve eradication rates of only 50 to 75% for E. faecalis prostatitis, which means a significant number of men need alternative or extended treatment regimens. If you’re a man with recurrent E. faecalis in your urine alongside symptoms like pelvic pain, difficulty urinating, or pain with ejaculation, prostatitis is worth discussing with your doctor.
What Your Results Mean in Practice
If your urine culture shows E. faecalis and you have no symptoms, the most likely scenario is that the bacteria are present without causing harm, and treatment isn’t necessary. If you do have UTI symptoms, it means your infection is caused by a bacterium that’s less common than E. coli but well understood, with effective treatment options available for most strains. The key factors that shape your treatment plan are whether you have symptoms, whether the strain shows any unusual resistance patterns on the sensitivity report, and whether you fall into a higher-risk group such as pregnancy, recent organ transplant, or catheter use.